| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 22.44▼ | 22.28▼ | 22.26▲ | 21.42▲ | 19.55▲ |
| MA10 | 22.45▼ | 22.29▼ | 22.45▼ | 20.53▲ | 21.18▲ |
| MA20 | 22.36▼ | 22.49▼ | 22.22▲ | 19.04▲ | 19.50▲ |
| MA50 | 22.26▲ | 21.62▲ | 21.04▲ | 20.74▲ | 49.73▼ |
| MA100 | 22.44▼ | 20.87▲ | 19.36▲ | 19.18▲ | 89.48▼ |
| MA200 | 22.26▲ | 19.25▲ | 19.78▲ | 36.25▼ | 97.67▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.084▼ | -0.107▼ | 0.580▲ | 2.682▲ |
| RSI | 43.989▼ | 51.859▲ | 58.934▲ | 58.907▲ | 41.466▼ |
| STOCH | 52.584 | 41.923 | 32.335 | 88.997▲ | 50.433 |
| WILL %R | -98.462▼ | -66.842 | -51.786 | -10.482▲ | -29.883 |
| CCI | -151.990▼ | -1.157 | -36.223 | 115.595▲ | 45.664 |
|
Wednesday, November 26, 2025 10:41 PM
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
|
|
Tuesday, November 25, 2025 08:07 AM
FDA approves dosing in Sarepta's ENDEAVOR Cohort 8 to test sirolimus with Elevidys in non-ambulant Duchenne patients, targeting reduced liver injury.
|
|
Monday, November 24, 2025 04:49 AM
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today shared progress in the Phase 1/2 multiple ascending dose (MAD) clinical study of SRP-1003 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/12/25 | 22.885 | 22.93 | 21.945 | 22.26 | 2,659,310 |
| 04/12/25 | 21.55 | 23.00 | 21.47 | 22.82 | 3,395,986 |
| 03/12/25 | 19.75 | 21.93 | 19.43 | 21.84 | 3,472,695 |
| 02/12/25 | 19.82 | 20.53 | 19.37 | 20.47 | 4,003,944 |
| 01/12/25 | 20.845 | 21.00 | 19.67 | 19.72 | 2,857,543 |
| 28/11/25 | 21.12 | 21.38 | 20.72 | 21.34 | 1,633,037 |
| 26/11/25 | 19.40 | 21.21 | 19.35 | 20.95 | 3,246,891 |
| 25/11/25 | 18.91 | 19.45 | 18.73 | 19.35 | 3,000,137 |
| 24/11/25 | 17.76 | 19.14 | 17.615 | 18.91 | 4,427,277 |
| 21/11/25 | 16.40 | 17.72 | 16.33 | 17.69 | 3,939,883 |
|
|
||||
|
|
||||
|
|